隔夜，COMEX黄金期货涨1.21%，报4505.50美元/盎司。 (责任编辑：张海蛟) 中国经济网北京1月7日讯 今日，上海期货交易所日间盘黄金期货主力合约震荡收低，成交放大，持仓 减少。主力2602合约收报998.90元，跌0.17%或1.74元;成交量为200099手;持仓为126146手，持仓减少 4081手。 ...

隔夜，WTI2月原油期货收跌1.19美元，跌幅2.04%，报57.13美元/桶。 中国经济网北京1月7日讯今日，上海国际能源交易中心日间盘原油期货主力合约震荡收跌，成交放大， 持仓增加。主力2602合约收报416.3元，跌2.57%或11.0元;成交量为110999手;持仓为32970手，日盘持仓 增加1374手。 ...

Core Insights - The export of frozen durians from Indonesia to China marks a significant achievement in agricultural product access between the two countries, enhancing technical discussions and quarantine cooperation [1] - The shipment, containing 23 tons of frozen durian flesh and puree, successfully established a maritime fast track for Indonesian fruits to the Chinese market, contributing to the development of the China-ASEAN (Qinzhou) Fruit Trading Center [1] Group 1 - The shipment departed from Jakarta on December 26, 2025, and arrived at the Qinzhou Comprehensive Bonded Zone on January 5, 2026, indicating efficient logistics and customs clearance [1] - The China-ASEAN (Qinzhou) Fruit Trading Center is implementing a rapid customs clearance model for imported fruits, known as "027," which allows for immediate release of non-targeted inspections and expedited processing for compliant shipments [1][1] - The establishment of a plant and animal inspection laboratory at Qinzhou port has expanded the qualification for 55 testing items, facilitating the "Qinzhou goods, Qinzhou inspection" initiative [1] Group 2 - From January to November 2025, a total of 29,000 tons of fruits and fruit products were imported through Qinzhou port, showcasing the growing trade volume in fresh produce [1]

Group 1 - Hubei Xingfu Electronics acquired proprietary technology and experimental equipment for the preparation of photoinitiators used in G/I line photoresists for 46.27 million yuan, aiming to break the long-standing foreign monopoly in the semiconductor field [1] - The photoinitiator technology is crucial for chip and display manufacturing, with over 95% of the domestic demand currently relying on imports from the US, Japan, and South Korea [1] - The project was initiated in response to market demand, with Hubei Sanxia Laboratory focusing on research in microelectronic materials, addressing the supply chain pressures faced by domestic semiconductor manufacturers [1][2] Group 2 - Hubei Xingfu Electronics aims to enter the photoinitiator industry but faces significant R&D risks, prompting collaboration with Hubei Sanxia Laboratory to develop the necessary technology [2] - After three years of R&D, the technology has reached a level comparable to foreign imports, with initial samples passing verification from multiple photoresist companies [2] - The project is in the early stages of industrialization and will establish Hubei's first production line for photoinitiators, contributing positively to the domestic photoresist industry [2][3] Group 3 - The industrialization project will create a complete supply chain from upstream materials to downstream chip manufacturing, enhancing the application of research outcomes [3] - Once operational, the domestic market share of G/I line photoresists is expected to reach over 50%, supporting the development of a trillion-level optoelectronic information industry cluster in Hubei [3]

1月6日，由粤港澳大湾区生成式人工智能安全发展联合实验室、深圳市福田区委主办的粤港澳大湾区生 成式人工智能安全发展联合实验室福田服务站启用暨AI出海研讨会在深圳举行。据悉，这是该联合实 验室将人工智能安全治理力量下沉至基层的创新之举，也是深圳构建"安全与发展并重"AI产业生态中迈 出的关键一步。 据了解，联合实验室是适应人工智能时代敏捷、弹性、高效的创新治理联合体，由广东省委网信办和国 家互联网应急中心广东分中心联合牵头，大湾区相关部门、企业、高校、科研机构等共同参与建设，运 行主体设在河套深港科技创新合作区深圳园区。福田服务站将承担大模型和算法备案辅导、安全评测、 合规培训、政策宣贯等职能，为企业提供"一站式、全周期、零距离"的专业支持。 "数据隐私问题不仅仅出现在大语言模型，也出现在视觉大模型。"吴保元表示，作为特殊的数据载体和 重要数据资产，AI模型及其相关数据属于跨境数据规定的监管范畴，而AI生成内容是否合规，与法律 法规、历史文化、宗教习俗、地域特点高度相关，需要根据出境目的地要求设置个性化的AI生成安全 护栏。 "福田服务站并非简单的'政策窗口'，而是为AI硬件企业破解发展痛点、打通商业化链路的关 ...

百花医药此前发布的《关于筹划控制权变更事项的停牌公告》《关于筹划控制权变更事项继续停牌 的公告》及上述最新公告均未对交易方进行披露。 由于公司控股股东、实际控制人与交易对方未就控制权变更相关重大事项达成一致意见，本着审慎 的原则，决定终止本次控制权变更事项。公司目前各项经营情况正常，终止筹划控制权变更事项不会对 公司经营业绩和财务状况产生重大不利影响。为维护投资者利益，根据相关规定，经公司向上海证券交 易所申请，公司股票于 2026 年 1 月 7 日（星期三）开市起复牌。 中国经济网北京1月7日讯 百花医药(600721.SH)今日复牌跌停，截至收盘报11.02元，跌幅9.97%。 该股停牌前的最后一个交易日（2025年12月26日）盘中最高涨9.00%。 百花医药昨日晚间披露关于终止筹划控制权变更事项暨复牌的公告。因公司控股股东、实际控制人 米在齐、米恩华、杨小玲正在筹划公司股份协议转让事宜，该事项可能导致公司控制权发生变更。鉴于 该事项正在洽谈当中，尚存在不确定性，为保证公平信息披露，维护投资者利益，避免造成公司股价异 常波动，经公司向上海证券交易所申请，公司股票自 2025 年 12 月 29 日（星 ...

Market Overview - The A-share market saw all three major indices rise, with the Shanghai Composite Index closing at 4085.77 points, up 0.05%, and a total trading volume of 1,197.42 billion yuan [1] - The Shenzhen Component Index closed at 14,030.56 points, up 0.06%, with a trading volume of 1,656.72 billion yuan [1] - The ChiNext Index closed at 3,329.69 points, up 0.31%, with a trading volume of 756.99 billion yuan [1] Sector Performance Top Gaining Sectors - Electronic chemicals led the gainers with a rise of 5.19%, total trading volume of 1,776.21 million hands, and a net inflow of 49.917 billion yuan [2] - Coal mining and processing increased by 4.02%, with a trading volume of 2,409.38 million hands and a net inflow of 10.97 billion yuan [2] - New metal materials rose by 2.44%, with a trading volume of 867.62 million hands and a net inflow of 3.49 billion yuan [2] Top Losing Sectors - Small home appliances experienced a decline of 1.36%, with a trading volume of 230.32 million hands and a net outflow of 7.96 billion yuan [2] - Black home appliances fell by 1.22%, with a trading volume of 304.02 million hands and a net outflow of 6.26 billion yuan [2] - IT services also decreased by 1.22%, with a trading volume of 3,712.05 million hands and a net outflow of 53.16 billion yuan [2]

Core Viewpoint - The company, Siwei Liekong (603508.SH), announced the termination of its planned change in control, which was under negotiation but did not reach an agreement among key stakeholders [1][2]. Group 1: Control Change Announcement - The company received notification from its controlling shareholders regarding a potential significant matter that could lead to a change in control on December 28, 2025 [1]. - Due to the ongoing negotiations and uncertainties, the company applied for a trading suspension starting December 29, 2025, to ensure fair information disclosure and protect investor interests [1]. - After thorough discussions, the parties involved decided to terminate the planned change in control, with no party bearing liability for breach of contract [1]. Group 2: Business Operations and Financial Impact - The company confirmed that its business operations remain normal, and the termination of the control change plan is not expected to have a significant adverse impact on its operational performance and financial condition [1]. - The company also disclosed that its former director and vice president, Zhao Jianzhou, had his detention lifted, and this incident did not affect the company's operations during the detention period [2].

Group 1 - The core viewpoint of the articles highlights the decline in the underwriting quality evaluation of Shenwan Hongyuan, which dropped from Class A to Class C, raising market concerns [1] - The Securities Association reported that out of 93 securities firms, 12 were rated Class A, 66 Class B, and 15 Class C, indicating a significant drop for Shenwan Hongyuan [1] - Shenwan Hongyuan has faced multiple regulatory penalties over the past year, which may have contributed to its downgrade in the evaluation [1] Group 2 - In March of the previous year, the Shanghai Stock Exchange issued four disciplinary actions against Shenwan Hongyuan for inadequate fulfillment of its sponsorship responsibilities during the IPO application process for Guohong Tools [1] - In April, the Shenzhen Stock Exchange announced self-regulatory measures against Shenwan Hongyuan related to the IPO project of Hainuoer, citing issues with internal controls and inaccurate verification opinions [1] - The Shanghai Municipal Communications Administration reported that two versions of Shenwan Hongyuan's APP were found to have user rights infringement issues, specifically difficulties in account cancellation [2]

中国经济网北京1月7日讯 药明康德（603259）(603259.SH)昨日晚间发布股东减持股份结果公告。公司 于2026年1月5日收到实际控制人控制的股东发出的《告知函》，截至2026年1月5日，实际控制人控制的 股东通过集中竞价和大宗交易方式累计减持公司股份59,675,143股，占公司总股本的2%。其中通过集中 竞价方式累计减持29,836,652股，通过大宗交易方式累计减持29,838,491股，受让方均为知名国际投资 者。本次减持计划已实施完毕。 2025年11月20日至2026年1月5日，G&C IV Hong Kong Limited减持11,490,579股，减持总金额为 1,028,765,036.20元；G&C V Limited减持8,028,865股，减持总金额为718,837,453.55元；G&C VI Limited 减持15,706,741股，减持总金额为1,406,252,948.58元；G&C VII Limited减持4,157,242股，减持总金额为 372,196,091.76元；嘉兴厚锦投资合伙企业（有限合伙）减持218,529股，减持总金额为19,652,625. ...